Chapter 4 - The Boardroom War
The transition from a condemned Bronx basement to the glass-and-marble luxury of the Carter Estate in Greenwich, Connecticut, was absolute.
Within forty-eight hours, Daniel had secured emergency legal custody of Maya Vance through his high-powered legal team. Maya was given her own wing of the estate—a bright, sunlit suite overlooking rolling gardens, furnished with a high-end medical library, a state-of-the-art computer station, and a grand four-poster bed.
Yet, Maya didn't care about the silk sheets or the designer clothes Olivia bought for her.
She spent her mornings sitting beside Olivia's rocking chair, gently checking baby Clara's reflexes with a tiny silver neurological hammer she had requested, and her afternoons reading advanced pharmacology journals that Daniel brought home from his office.
"Her neonatal lung development is exceptional," Maya noted one afternoon, sitting on the rug with a cup of warm chamomile tea, looking up at Olivia. "You should continue the vitamin D supplements for another three weeks."
Olivia laughed softly, holding Clara against her chest. "Yes, Dr. Maya. Anything else?"
"Don't let Daniel eat the salt pastrami," Maya added seriously. "His blood pressure was 138 over 88 this morning. He thinks I didn't see him check his cuff in the study."
Olivia looked over at Daniel, who was leaning against the doorway with a smile. "You heard the doctor, Daniel. No pastrami."
"I'm being managed by a seven-year-old," Daniel grumbled playfully, though his eyes shone with deep, unadulterated happiness.
For the first time in twelve years, the heavy, suffocating cloud of grief that had hung over Daniel's life was gone. His house was filled with the sounds of a newborn crying, a child reading, and a wife laughing.
However, outside the sanctuary of the Greenwich estate, a storm was brewing.
At 8:00 AM on Monday morning, Daniel’s Maybach pulled up to the subterranean executive garage of Carter Pharmaceuticals headquarters in Midtown Manhattan.
As Daniel stepped into the private executive elevator, Marcus leaned in.
"Boss, the board meeting at nine is going to be hostile," Marcus warned softly. "Arthur Pendelton has been gathering votes for the past three days."
Daniel’s expression turned cold. Arthur Pendelton was the senior vice-chairman of Carter Pharmaceuticals—a ruthless, seventy-year-old Wall Street titan who owned fourteen percent of the company's voting shares.
"Let him try," Daniel said calmly.
When Daniel entered the high-tech conference room on the 50th floor, the atmosphere was thick with tension. Twelve board members sat around a thirty-foot glass table.
At the far end sat Arthur Pendelton, immaculate in a pinstripe suit, his silver hair slicked back, a look of smug triumph across his wrinkled face.
"Daniel," Pendelton said, not bothering to stand. "So glad you could join us. We were beginning to think you were too preoccupied playing father to street urchins to manage a seventy-billion-dollar pharmaceutical empire."
Daniel walked to the head of the table and sat down. "Get to the point, Arthur."
Pendelton tossed a stack of documents onto the center of the glass table.
"The board has called a emergency vote under Section 4 of the corporate bylaws," Pendelton announced, looking around the room at the nervous board members. "Over the past seventy-two hours, national media has been saturated with videos of you kneeling in the slush on Fifth Avenue, screaming like a lunatic, while a homeless child delivered your infant."
"That 'homeless child' saved my wife and daughter's lives," Daniel said, his voice dangerously low.
"Be that as it may," Pendelton sneered, "your emotional instability since the incident has compromised investor confidence. Stock prices dipped three percent on Friday. Furthermore, we’ve learned you used corporate security assets and legal funds to illegally extract a child from state custody in the Bronx."
Pendelton stood up, leaning his heavy hands on the table.
"You've lost your edge, Daniel. You're bringing street charity into our ecosystem. Today, the board votes to remove you as Chief Executive Officer and suspend your clinical research oversight."
A heavy silence fell over the boardroom. Several board members looked away, unable to meet Daniel's eyes, while others nodded in agreement with Pendelton.
Before Daniel could speak, the frosted glass doors of the boardroom slid open with a soft pneumatic hiss.
A tiny figure walked smoothly into the room.
Maya was wearing a custom-tailored dark navy blazer over a crisp white shirt, pleated grey trousers, and shiny black leather shoes. She carried a sleek black leather folder under her arm.
Behind her walked Marcus, holding two large aluminum trial cases.
"Who allowed a child into an executive session?!" Pendelton shouted, turning purple with indignation. "Security! Clear this floor!"
"Sit down, old man," Maya said.
Her voice wasn't loud, but it possessed a sharp, cutting, authoritative frequency that instantly halted the guards at the door.
Maya walked straight to the center of the thirty-foot table, pulled out an executive leather chair, and hopped up onto it, setting her black folder on the glass.
She looked around at the twelve multi-millionaire executives with cool, clinical indifference.
"Arthur Pendelton," Maya said, reading his nameplate. "Seventy-two years old. You've had two coronary stent procedures at Mount Sinai. You take fifty milligrams of metoprolol daily, but your resting tremor in your left index finger suggests early-stage Parkinsonian onset that you've been hiding from the SEC disclosures."
Pendelton gasped, his hand instantly jerking into his pocket. "What... how dare you?!"
Maya opened her folder, sliding three colored charts across the glass toward the board members.
"I spent the last forty-eight hours reviewing Carter Pharmaceuticals' Phase III clinical trials for Cardio-Vex—the blood-thinning drug Arthur has been pushing to bring to market next quarter," Maya stated smoothly, her tone identical to a veteran FDA review chairman. "The molecular structure is unstable. Your research team altered the baseline liver toxicity metrics in the third-quarter trial to bypass regulatory clearance."
The room erupted into frantic murmurs.
"That's slander!" Pendelton screamed, slamming his fist down. "She's a child! She's making up medical fairy tales!"
"If you launch Cardio-Vex in its current formulation," Maya continued calmly, ignoring his outburst, "forty percent of patients over sixty-five will suffer acute hepatic failure within ninety days. The resulting class-action lawsuits will liquidate thirty billion dollars in corporate capital and destroy this company."
Maya looked at Daniel, offering a tiny, subtle nod.
"Daniel isn't losing his mind," Maya concluded, looking back at the board. "He's fixing your science. Now, if you want to vote to remove him, go ahead. But I’ll send the unredacted liver-toxicity raw data to the FDA and the Wall Street Journal in five minutes."
She pulled a small silver digital timer from her pocket and set it on the glass table.
It began to count down from 05:00.
The board members looked at the charts, then at Pendelton’s ghostly white face, then at the brilliant seven-year-old child sitting quietly at their table.
One by one, the board members lowered their hands.
"The motion to remove Daniel Carter," the lead independent director announced weakly, "is withdrawn."
May you like
Maya picked up her leather folder, hopped down from her chair, and walked toward the door. As she passed Daniel, she whispered softly:
"Told you I'd handle the meeting, Daniel. Now let's go home. Olivia made chicken soup."
